Navigation Links
Texcel Introduces Innovative Programmable, Implantable Stimulation System for R&D of Specialty Stimulation Therapies
Date:10/29/2008

EAST LONGMEADOW, Mass., Oct. 29 /PRNewswire/ -- Texcel, a leading provider of custom medical device development and manufacturing solutions, has introduced its innovative new StimX programmable, implantable stimulation system.

Designed for use in the research and development of specialty stimulation therapies, the StimX system is the industry's first-truly programmable, implantable customizable platform.

The StimX system's programmable stimulation parameters "will directly benefit medical researchers and medical device developers by dramatically reducing the time, cost, and risk involved in creating devices for use in testing stimulation therapies in a variety of applications," said Keith Checca, Texcel Director of Business Development.

"With the StimX implantable system, we are freeing researchers from the hours and dollars that they'd otherwise invest in designing and developing their own devices -- and to literally re-allocate their resources back into their research," said Checca.

Neural stimulation therapies, including direct nerve and brain stimulation, are used to treat people who suffer from epilepsy, Parkinson's disease, clinical depression and other diseases. Targeted stimulation areas range widely from direct brain surface, deep brain stimulation, to the spinal cord and peripheral nerves.

Texcel's new StimX platform includes an implantable stimulator, laptop and output customization program, proven wireless communication and charging modules.

The need for the system was realized as a result of Texcel's years of innovation in the field of custom medical device manufacturing and it was made possible by Texcel's partnerships with medical electronics development resources.

For more information, visit the Texcel website at: http://www.texcelmedical.com/stimx; or call the company at (413) 525-5700.

About Texcel

For more than 21 years, Texcel has partnered successfully with companies around the globe to accelerate the commercialization of their implantable, surgical, and interventional medical device technologies. Texcel is staffed with over fifty (50) talented, experienced, and passionate medical device industry employees within an ISO 13485 and ISO 9001 environment. Texcel provides specialized services and/or full medical device solutions including device design, development history file maintenance, quality (QA & QC), regulatory assistance, process validation, and general manufacturing, electronic testing, laser welding, and clean-room packaging for a wide range of product applications. Texcel is based in East Longmeadow, Mass. Visit Texcel on the Net at: http://www.texcelmedical.com.

Download high resolution images for publication from: http://www.flickr.com/photos/10956940@N08/2943759305/


'/>"/>
SOURCE Texcel
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Delta Dental of Illinois Introduces Smile Smart For Your Health
2. Highmark Blue Cross Blue Shield Introduces New Health Plan Comparison Tool for Consumers
3. Highmark Blue Shield Introduces New Health Plan Comparison Tool for Consumers
4. Sentillion Introduces Affordable Next Generation Healthcare Single Sign-On Solution Called expreSSO(TM)
5. GladRags Introduces the Moon Cup - An Environmentally-Sound and Safe Alternative to Disposable Feminine Hygiene Products!
6. Triveris Introduces Personal Health Record with Built-in Health Advisor
7. Verizon Introduces Broadband Video Call Center Link for Deaf or Hard-of-Hearing Customers in Mid-Atlantic Region
8. Mecklenburg EMS Introduces Most-Advanced Situational Training in America for Emergency Medical Personnel
9. Small Bone Innovations Introduces the Artelon(R) STT Spacer to Increase Treatment Options for Thumb Arthritis
10. Sentillion Introduces Affordable Next Generation Healthcare Single Sign-On Solution Called expreSSO(TM)
11. ThermoTx Introduces New Mobile Stimulation (TENS) Product Line for On the Go Therapy and Pain Relief
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/25/2017)... Marietta, GA (PRWEB) , ... April 25, 2017 ... ... implant and instrument solutions, announces the continuation of its strategic partnership with and ... surgeons in developing nations in the safe and effective management of complex spine ...
(Date:4/24/2017)... ORLANDO, FLORIDA (PRWEB) , ... April 24, 2017 ... ... of telehealth technology yesterday, featuring Bring Your Own Device (BYOD) capabilities at Telehealth ... compliment LG CNS’ pre-packaged telehealth bundles, which pairs medical devices with a pre-programmed ...
(Date:4/24/2017)... ... , ... The Santana Telehealth Project was honored with the 2017 ATA Humanitarian ... Association’s annual conference, on April 23 in Orlando, FL. , “I am proud that ... of the poor and underserved in other parts of the world,” said Jonathan Linkous, ...
(Date:4/24/2017)... ... ... As part of the nationwide Days of Remembrance effort led by the ... Nazi persecution, Center for Medicine after the Holocaust (CMATH) announced that it ... Germany and Poland next week. , The Fourth Biennial CMATH Champions Trip to Germany ...
(Date:4/24/2017)... ... 24, 2017 , ... The bar for just about everything—apparel, eyewear, cars and ... air of pop and film stardom.(1) Not to be left out is that most ... now run the gamut from being encrusted with jewels and precious metals to, at ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... , April 20, 2017  RXi Pharmaceuticals ... innovative therapeutics that address significant unmet medical needs, ... from the Company,s consumer product development program, based ... the Society for Investigative Dermatology (SID) 76 th ... advance and promote the sciences relevant to skin ...
(Date:4/20/2017)... April 20, 2017   ZappRx, Inc ., a digital ... prescribing process, today announced it closed $25 million in Series ... capital firm based in Seattle that ... Partners . The Series B round included participation from ... 2014, and GV (formerly Google Ventures). As part ...
(Date:4/20/2017)... 2017 Eyevensys, a private biotechnology ... gene expression technology that enables the safe, local, sustained ... a wide range of ophthalmic diseases, announces it has ... Regulatory Agency (MHRA) to advance its technology into clinical ... The ...
Breaking Medicine Technology: